Goodbody Health Limited.
(“Goodbody” or “Goodbody Health” the “Company” or the “Group”)
30th August 2022
Director Transfer of Ordinary Shares
The Company today announces that Geremy Thomas, the Executive Chairman and Director of the Company transferred 200,000 ordinary shares to an unrelated party for nil consideration on August the 30th 2022.
Post this transaction Geremy Thomas has an interest in 7,640,638 ordinary shares, representing approximately 20.94% of the issued share capital of the Company.
The Directors of the Company accept responsibility for the contents of this announcement.
On behalf of the Board of Directors,
For further information:
Chief Executive Officer
Goodbody Health Limited
+44 (0) 20 7971 1255
AQSE Corporate Advisor
Peterhouse Capital Limited
Guy Miller / Mark Anwyl
+44 (0) 20 7469 0930